晚期胆囊癌与高瘤突变负担:一个病例报告和文献综述

Juan Wang1,2, Jianmin Liu2,3, Chao Yan4

  • 1Department of Oncology, The Affiliated Hospital of Southwest Medical University, Luzhou, China.

AME case reports
|May 7, 2024
PubMed
概括

mFOLFIRINOX在晚期胆囊癌 (GBC) 中显示出有效性. 将免疫疗法与化疗相结合可能更有效,作为高瘤突变负担GBC的第一线治疗,需要进一步的临床验证.